SWAV News and Press, ShockWave Medical Inc. From 04/24/24

2024-04-24 08:50:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. Our portfolio outperformed the MSCI AC World Index in Q1 due to broad-based security ...

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, LABP, SWAV, FUSN NEW YORK, NY / ACCESSWIRE / April 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fid...

2024-04-11 13:10:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks were among the worst performers in 2023. And so far in 2024, investors are still waiting on the recovery rally. Many small-cap biotech stocks are being held back by the Fed&#...

2024-04-11 07:30:31 ET Summary Pharmaceuticals and medical devices giant Johnson & Johnson will report its first quarter 2024 results on Tuesday, April 16. In this earnings preview, I share my thoughts on JNJ's previous earnings and what can be expected from the upcoming repor...

MONSEY, N.Y., April 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $335.00 per share in cash for which Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) has agreed to be sold to Johnson & Johnson. The sales p...

2024-04-10 04:57:00 ET Johnson & Johnson (NYSE: JNJ) has focused more on growth initiatives since spinning off its consumer healthcare business into what is now Kenvue . In 2022, it made a big move with the acquisition of heart pump maker Abiomed for a whopping $16.6 billion...

SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the ful...

2024-04-08 09:15:06 ET Johnson Rice analyst issues NEUTRAL recommendation for SWAV on April 8, 2024 07:41AM ET. The previous analyst recommendation was Market Perform. SWAV was trading at $326.34 at issue of the analyst recommendation. The overall analyst consensus : HOL...

2024-04-05 12:30:03 ET Johnson Rice analyst issues HOLD recommendation for SWAV on April 5, 2024 10:37AM ET. SWAV was trading at $325.7 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, 4 - Hold, ...